WRN and cancer: They act in both homologous recombination initiation and in preventing aberrant exchanges [39], [40], and when WRN protein lacks helicase and exonuclease activities, the cancer-prone Werner syndrome ensues [41], which is characterized by an increased genomic instability and reduced homologous recombination [41].